Gene · 780
Papers2,465
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,465
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Icaritin Sensitizes Hepatocellular Carcinoma to PD-L1 Therapy by NQO1-Dependent Ferroptosis Induction. | Phytother Res | 2026 | 41806164 | PubTator, text mining | PubMed |
| Phosphatases in tumor cell immune escape: a perspective based on the camouflage, coercion, cytoprotection. | Front Cell Dev Biol | 2026 | 41799437 | PubTator, text mining | PubMed |
| 6PPD-quinone promotes ovarian cancer progression: Insights from network toxicology, machine learning, and in vitro validation. | Food Chem Toxicol | 2026 | 41796632 | PubTator, text mining | PubMed |
| Targeting DDR1 with novel synthesized antagonists delays cellular aging and enhances wound healing in mesenchymal stem cells. | Biomed Pharmacother | 2026 | 41793971 | PubTator, text mining | PubMed |
| The extracellular matrix in inflammation and cancer. | Mol Biomed | 2026 | 41787034 | PubTator, text mining | PubMed |
| Beyond the hype: navigating the real-world applications of artificial intelligence (AI) in healthcare. | Med Rev (2021) | 2026 | 41783894 | PubTator, text mining | PubMed |
| Mass spectrometry-based multi-omics analysis elucidates immune microenvironmental characteristics and the risk of distant metastasis in N1c colorectal cancer. | Front Immunol | 2026 | 41782869 | PubTator, text mining | PubMed |
| The Molecular Network of Neutrophil Extracellular Traps in Hepatocellular Carcinoma: Biogenesis, Function, and Therapeutic Implications. | Molecules | 2026 | 41752527 | PubTator, text mining | PubMed |
| Selective Inhibitor of Protein Kinase PKN3 Generated by Conjugation of a Structurally Optimized Bumped N-(2-Aminoethyl)-8-anilinoisoquinoline-5-sulfonamide (H-9) with d-Arginine-Rich Chain. | Molecules | 2026 | 41752364 | PubTator, text mining | PubMed |
| Immunosuppressive Environment of Pancreatic NENs-A Review. | Biomedicines | 2026 | 41751264 | PubTator, text mining | PubMed |
| From Latent Manifolds to Targeted Molecular Probes: An Interpretable, Kinome-Scale Generative Machine Learning Framework for Family-Based Kinase Ligand Design. | Biomolecules | 2026 | 41750280 | PubTator, text mining | PubMed |
| The critical role of discoidin domain receptors in the regulation of anti-tumor immune responses. | Int J Cancer | 2026 | 41741233 | PubTator, text mining | PubMed |
| Discoidin Domain Receptor 1 Translocation to the Mitochondria Promotes Oxidative Stress and Apoptosis in Acute Kidney Injury. | J Am Soc Nephrol | 2026 | 41734039 | PubTator, text mining | PubMed |
| Multi-cohort and single-cell profiling of aging genes reveals prognostic and therapeutic targets in breast cancer. | iScience | 2026 | 41732271 | PubTator, text mining | PubMed |
| WWC proteins as emerging biomarkers and therapeutic targets in cancer pathogenesis. | Front Cell Dev Biol | 2026 | 41727322 | PubTator, text mining | PubMed |
| Research progress on the influence of tumor microenvironment on immunotherapy for pancreatic ductal adenocarcinoma. | Open Med (Wars) | 2026 | 41726142 | PubTator, text mining | PubMed |
| Nanoengineered Niclosamide as a Microenvironment Modulator for Spinal Cord Regeneration: A Hypothetical Roadmap Toward Brain/Head Transplant Feasibility. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2026 | 41725352 | PubTator, text mining | PubMed |
| Identification of circulatory neuro-related proteins in Parkinson's disease: an integrated genetic-proteomic-clinical study. | EBioMedicine | 2026 | 41724112 | PubTator, text mining | PubMed |
| Synergistic effects of radiotherapy and immunotherapy: improving oncological outcomes. | Front Immunol | 2026 | 41716387 | PubTator, text mining | PubMed |
| Beyond the membrane: Internalization and compartmentalization of insulin‑like growth factor 1 receptor signaling in cancer pathogenesis and treatment (Review). | Int J Oncol | 2026 | 41716020 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/780/papers?page=3